Literature DB >> 9757954

Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons.

M J Rosenberg1, M S Waugh.   

Abstract

OBJECTIVES: Our purpose was to define the frequency and reasons for oral contraceptive discontinuation and subsequent contraceptive behavior. STUDY
DESIGN: A nationwide prospective study of 1657 women initiating or switching to the use of a new contraceptive from private practices, clinics, and a health maintenance organization was performed.
RESULTS: Six months after a new oral contraceptive prescription, 68% of new starts and 84% of switchers still used oral contraceptives. Of women who discontinued, 46% did so because of side effects, whereas 23% had no continuing need. More than four fifths of women who discontinued oral contraceptives but remained at risk of unintended pregnancy either failed to adopt another method or adopted a less effective method. Fifteen percent of women who discontinued oral contraceptives resumed their use within the 7-month follow-up period.
CONCLUSIONS: Counseling should emphasize the possibility of side effects, stressing the fact that most will be transient, and the need to identify a backup method. Follow-up visits should be scheduled for 1 to 2 months after a prescription is written.

Entities:  

Keywords:  Americas; Contraception; Contraception Termination--women; Contraceptive Methods; Contraceptive Usage--women; Developed Countries; Family Planning; North America; Northern America; Oral Contraceptives; Research Report; United States; Women

Mesh:

Substances:

Year:  1998        PMID: 9757954     DOI: 10.1016/s0002-9378(98)70047-x

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  68 in total

Review 1.  Triphasic versus monophasic oral contraceptives for contraception.

Authors:  Huib A A M Van Vliet; David A Grimes; Laureen M Lopez; Kenneth F Schulz; Frans M Helmerhorst
Journal:  Cochrane Database Syst Rev       Date:  2011-11-09

Review 2.  Studying the use of oral contraception: a review of measurement approaches.

Authors:  Kelli Stidham Hall; Katharine O'Connell White; Nancy Reame; Carolyn Westhoff
Journal:  J Womens Health (Larchmt)       Date:  2010-10-30       Impact factor: 2.681

3.  Efficacy and safety of a low-dose 21-day combined oral contraceptive containing ethinylestradiol 20microg and drospirenone 3mg.

Authors:  D Cibula; U Karck; H G Weidenhammer; J Kunz; S Alincic; J Marr
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

4.  Oral contraceptive discontinuation: do side effects matter?

Authors:  Carolyn L Westhoff; Stephen Heartwell; Sharon Edwards; Mimi Zieman; Gretchen Stuart; Carrie Cwiak; Anne Davis; Tina Robilotto; Linda Cushman; Debra Kalmuss
Journal:  Am J Obstet Gynecol       Date:  2007-04       Impact factor: 8.661

5.  User satisfaction with the combined oral contraceptive drospirenone 3 mg/ethinylestradiol 20 microg (Yasminelle) in clinical practice: a multi-country, questionnaire-based study.

Authors:  Mary Short
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

6.  Adolescent experiences with the vaginal ring.

Authors:  Laura B Epstein; Karen Sokal-Gutierrez; Susan L Ivey; Tina Raine; Colette Auerswald
Journal:  J Adolesc Health       Date:  2008-03-10       Impact factor: 5.012

7.  Oral contraceptives and the risk of gallbladder disease: a comparative safety study.

Authors:  Mahyar Etminan; Joseph A C Delaney; Brian Bressler; James M Brophy
Journal:  CMAJ       Date:  2011-04-18       Impact factor: 8.262

Review 8.  Long-acting injectable hormonal dosage forms for contraception.

Authors:  Linfeng Wu; Dileep R Janagam; Timothy D Mandrell; James R Johnson; Tao L Lowe
Journal:  Pharm Res       Date:  2015-04-22       Impact factor: 4.200

9.  A randomized controlled study of two educational interventions on adherence with oral contraceptives and condoms.

Authors:  Abbey B Berenson; Mahbubur Rahman
Journal:  Contraception       Date:  2012-07-25       Impact factor: 3.375

10.  Effects of depot medroxyprogesterone acetate and 20-microgram oral contraceptives on bone mineral density.

Authors:  Abbey B Berenson; Mahbubu Rahman; Carmen Radecki Breitkopf; Lian X Bi
Journal:  Obstet Gynecol       Date:  2008-10       Impact factor: 7.661

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.